Search Results

Addressing PK/PD Study Design Early in Development.

• Authors : Mirasol, Feliza

Subjects: BIOTHERAPY; EXPERIMENTAL design; DRUG delivery systems

• Source: Pharmaceutical Technology. Feb2024, Vol. 48 Issue 2, p32-33. 2p.

Record details

AAD Updates AD Management Guidelines for Using Phototherapy and Systemic Therapies.

• Authors : Bader, Kaitlyn

Subjects: THERAPEUTIC use of antimetabolites; BIOTHERAPY; THERAPEUTIC use of monoclonal antibodies

• Source: Dermatology Times. Dec2023, Vol. 44 Issue 12, p32-35. 4p.

Record details

Applied Science & Technology Full Text (H.W. Wilson)

Record details

Efficacy and Mechanisms of Natural Products as Therapeutic Interventions for Chronic Respiratory Diseases.

• Authors : Jin, Fanli (AUTHOR); Fan, Pengbei (AUTHOR); Wu, Yuanyuan (AUTHOR)

Subjects: INFLAMMATION prevention; BIOTHERAPY; RESPIRATORY disease prevention

• Source: American Journal of Chinese Medicine. 2024, Vol. 52 Issue 1, p57-88. 32p.

Record details

"Patient remodeling" as a consequence of uncontrolled and prolonged OCS use in severe asthma: how biologic therapy can reverse a dangerous trend.

• Authors : Perlato, Margherita (AUTHOR); Mecheri, Valentina (AUTHOR); Vivarelli, Emanuele (AUTHOR)

Subjects: BIOTHERAPY; ASTHMA; WEIGHT gain

• Source: Journal of Asthma. Jan2024, Vol. 61 Issue 1, p72-75. 4p.

Record details

Cost-effectiveness and resource use analysis of patients with asthma before and after treatment with mepolizumab in a real-life setting.

• Authors : Domínguez-Ortega, Javier (AUTHOR); Laorden, Daniel (AUTHOR); Vílchez-Sánchez, Francisca (AUTHOR)

Subjects: ASTHMATICS; COST effectiveness; BIOTHERAPYSPAIN

• Source: Journal of Asthma. Jan2024, Vol. 61 Issue 1, p39-47. 9p.

Record details

Efficacy of mepolizumab and omalizumab combination therapy in uncontrolled asthma.

• Authors : Sezgin, Mehmet Emin (AUTHOR); Çolak, Mustafa (AUTHOR); Çağlayan, Özge (AUTHOR)

Subjects: OMALIZUMAB; ASTHMA; PULMONARY function tests

• Source: Journal of Asthma. Feb2024, Vol. 61 Issue 2, p173-175. 3p.

Record details

FDA Issues CRL for Odronextamab for Lymphoma Indications.

Subjects: BIOTHERAPY; THERAPEUTIC use of monoclonal antibodies; NON-Hodgkin's lymphomaUNITED States. Food & Drug Administration

• Source: Formulary Watch. 3/25/2024, p3-3. 1p.

Record details

Psoriasis Therapies in 2024 and Beyond.

• Authors : Brownstone, Nicholas

Subjects: BIOTHERAPY; PSORIASIS treatment; PSORIASIS

• Source: Dermatology Times. Jan2024, Vol. 45 Issue 1, p22-25. 3p.

Record details

Incremental net monetary benefit of biologic therapies in moderate to severe asthma: a systematic review and meta-analysis of economic evaluation studies.

• Authors : Veettil, Sajesh K. (AUTHOR); Vincent, Vanessa (AUTHOR); Shufelt, Taylor (AUTHOR)

Subjects: BIOTHERAPY; ASTHMATICS; PURCHASING power parity

• Source: Journal of Asthma. Sep2023, Vol. 60 Issue 9, p1702-1714. 13p.

Record details